| 胆管癌免疫治疗的研究进展 |
| |
| 引用本文： | 郭雪冉1,仲飞1,' target='_blank'>2. 胆管癌免疫治疗的研究进展[J]. 现代肿瘤医学, 2020, 0(11): 1969-1973. DOI: 10.3969/j.issn.1672-4992.2020.11.037 |
| |
| 作者姓名： | 郭雪冉1 仲飞1 ' target='_blank'>2 |
| |
| 作者单位： | 1.安徽医科大学第一附属医院，安徽 合肥 230022;2.安徽医科大学附属阜阳医院，安徽 阜阳 236000 |
| |
| 基金项目： | 安徽省卫计委中医药科研课题（编号:2016zy34） |
| |
| 摘 要： | 近些年来,随着生物治疗技术的发展,免疫治疗成为了目前肿瘤治疗研究的热点。胆管癌(cholangiocarcinoma,CCA)恶性程度高,预后不良,发病率逐年攀升,起病隐匿且易转移,诊断时多已发展至晚期,仅有20%的患者可以得到根治手术切除,因此迫切需要新的方法来延长晚期CCA患者的总体生存期。为寻求新的治疗模式,国内外已开展了大量临床研究,其中免疫治疗在胆管癌治疗中越来越受到关注。本文就胆管癌免疫治疗的相关研究进展作一综述。
|
| 关 键 词： | 免疫治疗 胆管癌 研究进展 |
The research progress of immunotherapy in cholangiocarcinoma |
| |
| Guo Xueran1,Zhong Fei1,' target='_blank'>2. The research progress of immunotherapy in cholangiocarcinoma[J]. Journal of Modern Oncology, 2020, 0(11): 1969-1973. DOI: 10.3969/j.issn.1672-4992.2020.11.037 |
| |
| Authors: | Guo Xueran1 Zhong Fei1 ' target='_blank'>2 |
| |
| Affiliation: | 1.The First Affiliated Hospital，Anhui Medical University，Anhui Hefei 230022，China；2.Affiliated Fuyang Hospital，Anhui Medical University，Anhui Fuyang 236000，China. |
| |
| Abstract: | In recent years，as biological therapy develops，immunotherapy has become the focus of tumor therapy research.Cholangiocarcinoma has a high degree of malignancy，poor prognosis，and increasing incidence year by year.The onset of the disease is latent and easy to metastasize.Most of the patients have advanced diagnosis，and only 20% of the patients can get radical surgical resection.So as to find a new treatment mode，numerous clinical trials have been carried out both here and abroad，among which immunotherapy has attracted more and more attention in cholangiocarcinoma.This article reviews the research progress of immunotherapy for cholangiocarcinoma. |
| |
| Keywords: | immunotherapy cholangiocarcinoma research progress |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载免费的PDF全文 |
